Scholars Central

Conference abstractPublished 23 Oct 2019

Transmucosal delivery of nanoparƟ cles and recombinant anƟ gens intended for mucosal vaccinaƟ on and therapeuƟ c applicaƟ ons

Authors: Eliška Mašková

Veterinary Research InsƟ tute, Czech Republic

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Transmucosal drug delivery brings many advantages including delivery of macromolecules, recombinant anƟ gens, allergens and nanoparƟ cle-based therapeuƟ cs. The oral mucosa, especially its sublingual region, is densely populated with specialized dendriƟ c cells, and therefore has been recognized as a suitable immunoinducƟ ve area giving the opportunity for safe and effi cient mucosal vaccinaƟ on and immunomodulaƟ on. Easy access for self-administraƟ on, high permeability, a lack of enzymaƟ c barriers, mild pH values, avoiding fi rst-pass metabolism, all make the non-keraƟ nized oral regions aƩ racƟ ve sites for the applicaƟ on of drugs and vaccines. The innovaƟ ve dosage form for delivery of recombinant anƟ gens and therapeuƟ c nanoparƟ cles through mucosal Ɵ ssues consists of a protecƟ ve backing layer, a mucoadhesive layer, and an electrospun nanofi brous layer. The mucoadhesive fi lm layer was prepared by solvent-casƟ ng method, and it is responsible for Ɵ ght adhesion of the whole system to the oral mucosa.nThe electrospun nanofi brous reservoir layer prepared using the electrospinning process is intended to act as a reservoir for recombinant anƟ gen, allergens and nanoparƟ cles. As an example, the effi ciency of transmucosal delivery of model polymeric PLGA-PEG nanoparƟ cles was tested using home-made Franz diff usion cells on freshly excised porcine sublingual mucosa. Intramucosal delivery was observed on cross-secƟ oned porcine sublingual mucosa using confocal microscopy. Overcoming the mucosal barriers is the main prerequisite for successful delivery of nanoparƟ cle-based drugs and immunotherapeuƟ cs into submucosal Ɵ ssues. In this work, we demonstrated the capability of nanofi bre-based mucoadhesive films to eff ecƟ vely deliver nanoparƟ cles into the submucosal Ɵ ssue. It provides a novel approach in the development of non-invasive sublingual vaccines and immunotherapeuƟ cs.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectNanotechnology
  • SubjectVaccines & Immunisation
  • BylineArticles whose byline prints “Eliška Mašková”